Management Forum Logo

Presented by
Management Forum

US Patent Practice Training Course

What all European patent attorneys need to know - an intensive and highly interactive two-day seminar including discussions on US patent law and strategies and tactics for patent prosecution at the US Patent Office

★★★★★ "Excellent! Very good and helpful overview of US patent law with a focus on the differences to Europe... more (14)"

13-14 June 2024
+ 8-11 October 2024 »

from £999

Need help?  Enrol or reserve

Course overview

The area of US patent practice can be complex and confusing. Are you up to date with the latest court decisions and best practice?

This highly interactive seminar will give you a comprehensive understanding of the US patent system and enable you to work more effectively with your US counterparts. It will highlight the important differences between US and European patent practice and provide you with the opportunity for in-depth discussions about prosecution practice and procedure throughout the two days. The programme will cover important tactics to get the most out of your prosecution dollar, and provide lots of claim drafting tips to give your application a solid footing for US prosecution and enforcement.

This event will bring you right up to date on the latest legislative changes under the America Invents Act (AIA), as well as all the recent and pending US Supreme and other court decisions of importance. You will also get to grips with current happenings in the USPTO that could impact on your role.

Key topics covered:

  • Legal framework
  • Claim construction
  • US patent prosecution practice and procedure
  • The written description, enablement and best mode requirements
  • Definiteness
  • Statutory subject matter
  • Novelty and prior art
  • Obviousness
  • Provisional and continuing applications
  • Restriction practice and obviousness
    • Type double patenting
  • USPTO programs
  • Patent Law Treaty implementation
  • Duty of candor
  • Infringement
  • Patent litigation and damages

This course is part of our collection of IP & Patents Training Courses.

Why you should attend

This is a fantastic opportunity to take full advantage of the open seminar environment that this event offers. With a high degree of interaction with the expert trainers as well as other participants, this is a great forum for discussing your particular questions and concerns. Offering a wide-ranging and detailed understanding, this seminar covers what every European patent practitioner should know about US patent practice.

Who should attend?

  • Corporate patent counsel
  • Patent attorneys from corporate and private practice
  • Intellectual property consultants
  • Patent managers and engineers
  • Company legal advisers
  • All those involved with patent protection in the United States

Enrol or reserve

The US Patent Practice course will cover:

Legal framework

  • Statutes and rules
  • Courts and agencies
  • Requirements for patentability

Claim construction

  • Phillips – broad multifaceted inquiry
  • Claim construction rules and guidelines
  • Claim construction in the USPTO

US patent prosecution – general flow of events

Written description

  • ‘Possession’ of claimed invention
  • Ariad – increased focus on what inventors actually did
  • Written description guidelines
  • Negative limitations


  • Wands factors – to show whether the amount of experimentation necessary would be ‘undue’
  • Interplay with written description requirement

Best mode

  • Effect of the AIA


  • Nautilus – the ‘reasonable certainty’ standard
  • USPTO practice

Means-plus-function claiming

Statutory subject matter

  • Supreme Court jurisprudence
  • USPTO guidance
  • Court of Appeal


  • Impossibility
  • Judicial interpretation

Patent Law Treaty implementation

Novelty and prior art

  • Anticipation
  • Pre-AIA – ‘first to invent’
  • Post-AIA – ‘first to file’

Novelty and prior art

  • Anticipation
  • Pre-AIA – ‘first to invent’
  • Post-AIA – ‘first to file’


  • Graham and KSR
  • USPTO practice – prima facie obviousness
  • USPTO KSR guidelines
  • Method claims

Provisional applications

  • Pre-AIA vs post-AIA

Continuing applications

  • Continuations, divisionals, continuations-in-part

Restriction practice

  • Restriction requirement
  • Restriction vs Election of Species
  • Rejoinder

Patent term and PTA

Obviousness – type double patenting

  • Gilead cases
  • Terminal disclaimers

USPTO programs

  • Terminal disclaimers

Patent Law Treaty implementation

Obviousness – type double patenting (continued)

  • Accelerated examination, track one, patent prosecution highway
  • First action interview, after-final consideration, pre-appeal brief request for review pilot programs

Duty of candor

  • Citation of references
  • Inequitable conduct


  • Conception
  • Joint inventorship
  • Interference practice
  • Derivation actions

Post-issuance practice

  • Re-examination and re-issue
  • Inter partes review
  • Post-grant review
  • Covered business method review
  • Supplemental examination
  • Certificates of correction


  • Direct infringement
  • Contributory infringement and inducement
  • Extraterritorial infringement
  • Exhaustion

Doctrine of equivalents

  • Function/way/result test
  • Festo – prosecution history estoppel
  • Licensing


  • Opinions

Declaratory judgment

  • Burdens of proof

Patent litigation and damages

  • Remedies
  • Entire market value
  • Injunctive relief

Enrol or reserve

James Suggs
McDonnell Boehnen Hulbert & Berghoff LLP

James V. Suggs is a partner in the intellectual property law firm McDonnell Boehnen Hulbert & Berghoff LLP, located in Chicago, where he practices patent law and serves as Chair of the firm’s Chemical Practice Group. He applies his broad technical experience in a wide variety of chemical, polymer, materials science, pharmaceutical, optical, photonic, semiconductor and related technologies. He handles all facets of patent law, with an especial focus in patent procurement, strategic counseling, freedom-to-operate and due diligence opinions.

He also has an active inter partes review practice. His litigation experience includes federal district court and appellate practice as well as advocacy in forums such as the International Trade Commission, and spans a diverse range of technologies. He has experience with all kinds of clients, from large multinational corporations, to science-based startups, to academic research institutions, and works with law firms in Europe and worldwide to successfully prosecute their applications at the USPTO.

More details

Nicole Reifman
McDonnell Boehnen Hulbert & Berghoff LLP

Nicole Reifman is a partner with McDonnell Boehnen Hulbert & Berghoff LLP, Chicago where she has gained diverse experience in obtaining, evaluating and enforcing intellectual property. She has experience in all phases of patent preparation and prosecution, and concentrates in representing clients in the mechanical and electrical arts, including drive train systems, medical devices, electromechanical, telecommunications and material sciences matters. She also has experience in all phases of patent litigation.

She provides counselling regarding the procurement, enforcement, and licensing of intellectual property rights, including trademark, trade secret and copyright issues. She actively manages trademark portfolios and develops brand building and protection strategies for her clients. She is also the Recent Developments Editor of the University of Illinois Journal of Law, Technology, and Policy.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

13-14 June 2024

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 13727

  • GBP 1,199
  • EUR 1,719
  • USD 1,959

View basket 

Not ready to book yet?

for 7 days, no obligation

8-11 October 2024

Live online

13:30-17:00 UK (London) (UTC+01)
14:30-18:00 Paris (UTC+02)
08:30-12:00 New York (UTC-04)
Course code 13956

  • GBP 999 1,199
  • EUR 1,439 1,719
  • USD 1,647 1,959

Until 03 Sep

View basket 

Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Reviews of IPI's US Patent Practice training course

The content, the presentation and the speaker were very good. All topics were presented in a clear manner.

Dec 15 2022

Italian Patent Attorney, Eni SpA

Dec 5 2019

Excellent! Very good and helpful overview of US patent law with a focus on the differences to European law. I particularly liked the very interactive discussions.

Hendrik Freudenberger
IP Legal Advisor, Sasol Chemie GmbH & Co. KG

Dec 5 2019

Very thorough and well presented.

Elisabetta Mauri
Director of Intellectual Property, Dompé Farmaceutici SPA

Dec 5 2019

The course gives European practitioners a good overview of the peculiarities of US patent law and the ways in which US practice sometimes differs from our own. The presentation was lively and the speakers provided plenty of background from their own experience.

Erik Bartelds
patent attorney, Arnold + Siedsma

Dec 4 2018

Excellent speakers.

Omar Jabarti
Engineer, Saudi Aramco

Jun 13 2018

A great overview, excellent speakers with comprehensive knowledge.

Peter Atzmüller
Key Patent Information Professional, voestalpine Stahl GmbH

Jun 13 2018

The course was exactly what I expected with a good quality of written documentation and highlighting of specific ongoing topics by the speakers.

Andreas Bazzon
Patent Attorney Candidate, Kaminski Harmann Patentanwälte AG

Jun 13 2018

Both entertaining and educative.

Lorenz Kallenbach
Corporate Patent Counsel, Merck

Jun 13 2018

The dual presentation works well. Interaction with audience very positive. Comprehensive update on US patent practice by knowledgeable speakers in an interactive atmosphere.

Marijke Hogenbirk
Senior Patent Attorney , Shell International B.V.

Jun 13 2018

The speakers were very direct and the course was interactive – I never for a minute lost interest.

Asteria Zitrou
Intellectual Property Supervisor, Pharmathen

Jun 14 2017

The course gave a very good general picture of US patent practice and I really liked all the real-life examples.

Leena Marquis
Patent Engineer, Seppo Laine Oy

Jun 14 2017

The presenter was engaging and open to questions.

Claire Goodier
Director of Intellectual Property, International, The Boots Company plc

Dec 5 2016

The speakers are excellent.

Paul Van Helvert
Manager Intellectual Property, Wageningen UR

Dec 5 2016

Entertaining and interesting programme.

Patrick John Couzens
Patent Attorney, Société des Produits Nestlé S.A.

United Kingdom

  • AA Thornton & Co
  • Albany International Ltd
  • ARM Holdings plc
  • AstraZeneca PLC
  • AstraZeneca R&D Charnwood
  • BOC Limited
  • Boult Wade Tennant
  • BP International Ltd
  • BT Group Legal
  • Cambridge Display Technology Ltd
  • Croda Europe Limited
  • D Young & Co LLP
  • Danfoss
  • David H L Edwards Ltd
  • De La Rue International Ltd
  • Dechert LLP
  • DePuy International Limited
  • Dupont Teijin Films UK Ltd
  • Element Six Ltd
  • Eli Lilly & Co Ltd
  • GE Healthcare UK Ltd
  • Glory Global Solutions
  • Hoffmann Eitle
  • Hoffmann Eitle & Partner
  • Infineum UK Ltd
  • ip21 Limited
  • Kennedys Patent
  • Lifescan Scotland Ltd
  • Mewburn Ellis LLP
  • Nissan Technical Centre Europe
  • Nokia UK Ltd
  • NXP Semicondutors
  • Olswang LLP
  • ORANGE Ltd
  • Oxford Gene Technology IP Ltd
  • Pfizer Limited
  • Procter & Gamble Technical Centres Limited
  • Procter & Gamble Technical Centres Ltd
  • QinetiQ Limited
  • R G C Jenkins & Co
  • Rolls Royce PLC
  • Schlumberger Cambridge Research
  • Sharp Laboratories of Europe Limited
  • Sharp Life Science (EU) Limited
  • Solexa
  • Sony Europe Limited
  • Stratagem IPM Limited
  • Syngenta Limited
  • Teva UK Ltd
  • The Boots Company plc
  • u-blox Melbourn Ltd
  • Unilever PLC
  • Vectura Group plc
  • Warwick Partnership Ltd
  • Williams Powell
  • Wolfson Microelectronics PLC
  • Xeros Limited


  • AOMB Intellectual Property Consultants
  • Arnold & Siedsma
  • Arnold + Siedsma
  • ASM
  • ASML Netherlands BV
  • Draka Comteq Fibre BV
  • DSM IP & Licensing BV
  • EDP Patent Attorneys B.V.
  • EP&C
  • Exter Polak & Charlouis b.v.
  • Genmab B.V.
  • Helze BV
  • Liquavista BV
  • NLO
  • Nutricia Research BV
  • Octrooibureau Van der Lely N.V.
  • Philips International B.V. - IP&S
  • Shell International B.V.
  • Shell International BV
  • TBG Europe NV
  • TomTom International B.V.
  • Unilever Patent Group
  • Unitpat B.V.
  • V.O.
  • Wageningen UR


  • Alk Abello
  • Ambu A/S
  • Awapatent A/S
  • Budde Schou
  • Chas Hude A/S
  • Coloplast A/S
  • Dako Denmark A/S
  • DuPont Nutrition Biosciences ApS
  • Ferring Pharmaceuticals
  • Fertin Pharma A/S
  • Genmab A/S
  • Glycom A/S
  • Hoiberg A/S
  • Høiberg P/S
  • Leo Pharma A/S
  • Nokia Danmark A/S
  • Novo Nordisk A/S
  • Patentgruppen A/S
  • Santaris Pharma
  • Widex A/S


  • 7000 andrees Patentanwaltskanzlei
  • Bardehle Pagenberg Partnerschaft mbB
  • European Patent Office
  • Grunenthal GmbH
  • Hafner and Partner
  • Henkel KGaA
  • OSRAM Opto Semiconductors GmbH
  • Procter & Gamble Service GmbH
  • Sasol Chemie GmbH & Co. KG
  • Umicore AG & Co. KG
  • Volkswagen AG
  • White & Case LLP
  • YARA Digital Farming


  • Actelion Pharmaceutical Ltd
  • Alstom Technology Ltd
  • Bemido SA
  • F. Hoffmann-La Roche AG
  • F. Hoffmann-La Roche Ltd
  • Geistlich Pharma AG
  • Merck
  • Nestec SA
  • Novartis Pharma AG
  • Procter & Gamble
  • Roche Diagnostics Ltd
  • Schneider Feldmann AG
  • Société des Produits Nestlé S.A.


  • AB Electrolux
  • Alfa Laval Corporate AB
  • Aros Patent AB
  • Brann AB
  • Ericsson AB
  • Ericsson AB (EAB)
  • Hansson Thyresson Patentbyra AB
  • Östlund Patent AB
  • Sony Mobile Communications AB
  • Spotify
  • Spotify AB
  • Valea AB
  • Zacco Sweden AB


  • Alfa Wassermann S.p.A.
  • Barzano&Zanardo Roma spa
  • chiesi farmaceutici
  • Chiesi Farmaceutici SPA
  • Dompé Farmaceutici SPA
  • Eni SpA
  • Invatec SRL
  • Pirelli & C SPA
  • Provvisionato & Co S.r.l.
  • Sealed Air S.r.l.
  • Sisvel SpA
  • Solvay Solexis SpA
  • Studio Bonini Srl


  • Beloem
  • CNH Industrial Belgium NV
  • De Clercq & Partners
  • ExxonMobil Chemical Europe Inc
  • Fujirebio-Europe NV
  • IMEC vzw
  • Janssen Pharmaceutica NV
  • P&G
  • Sofics BVBA
  • Umicore Research & Development
  • Yara SA/NV


  • Berggren Oy Ab
  • Kemira OYJ
  • Kolster OY AB
  • Microsoft Mobile Oy
  • Primrose Oy
  • Seppo Laine Oy
  • Tampereen Patenttitoimisto Oy
  • UPM-Kymmene Corporation
  • VTT (Technical Research Centre of Finland)


  • Cabinet Barre Laforgue & Associes
  • Cabinet Michel Richebourg
  • Cabinet NONY
  • Chanel PB
  • Medincell
  • SEB Developpement


  • Corporación Medichem, S.L.
  • J Uriach Y Compania
  • KAO Corporation S.A.
  • Oficini Ponti, S.L.
  • Uriach
  • ZBM Patents S.L.


  • Borealis Polyolefine GmbH
  • Sandoz GmbH
  • Sonn & Partner
  • Valneva Austria GmbH
  • voestalpine Stahl GmbH


  • EUPATENT.PL Adam Pawlowski
  • Patpol Kancelaria Patentowa sp. z o.o.
  • Patpol Kancelaria Patentowa sp. z.o.o.


  • Chinoin Zrt - member of sanofi-aventis Group
  • EGIS Pharmaceuticals PLC
  • Gedeon Richter Plc


  • Kaminski Harmann Patentanwalte
  • Kaminski Harmann Patentanwälte AG
  • Kaminski Harmann Patentwalte


  • Industrial Property Portuguese Office
  • J E Dias Costa, Lda
  • Raul Cesar Ferreira (Herd) SA


  • GE India Technology Centre Pvt Ltd
  • Tata Steel


  • StatoilHydro ASA
  • Yara International

Saudi Arabia

  • Al-Elm Information Security
  • Saudi Aramco


  • China Sinda Intellectual Property Pte Ltd
  • Panasonic Singapore Laboratories

United States of America

  • Microsoft Mobile Oy
  • Scynexis Inc


  • Novelis Inc


  • Pharmathen

Hong Kong


North Macedonia

  • Alkaloid AD


  • Technology Company Schlumberger


  • LEK Pharmaceuticals d.d.


  • Sanovel Pharmaceutical INC

Enrol or reserve

Run US Patent Practice Live online for your team

3 days

Typical duration

Pricing from:

  • GBP 1,200
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online


We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Training expert

+44 (0)20 7749 4749